In the News
Is fraud the business model of the prescription drug industry?

20th December 2016
Yes according to Democrat Bernie Sanders who is using the inter-regum between the Presidential election and the inauguration of Donald Trump to push his campaign alleging price gouging by the leading US pharmaceutical giants.
The business model of the pharmaceutical industry is fraud. They lie and collude to drive prices up. https://t.co/BGNF1Ij3E2
— Bernie Sanders (@SenSanders) December 18, 2016
More here
NEWS: Cummings, Sanders Raise Concerns about Heritage’s Assertions to Congress While Engaged in Alleged Price Fixinghttps://t.co/GwmR3js8zf
— Bernie Sanders (@SenSanders) December 16, 2016
Pharmaceutical executives must be held accountable for ripping off the American people. Fraud can no longer be an acceptable business model. https://t.co/iVveMawSW8
— Bernie Sanders (@SenSanders) December 14, 2016
I was struck in particular by an article in the FT that claimed the price of a routine anti-worming treatment is hundreds of times more expensive in the US than it is when paying over-the-counter in the UK. The brand Impax sells tapeworm treatment course for $880 v £3.50 in UK for the same treatment Ovex.
Staggering price gouging - Impax sells tapeworm treatment course for $880 v £3.50 in UK - itching to use in class https://t.co/OCwslkJY68
— Tutor2u Geoff (FRSA) (@tutor2uGeoff) December 18, 2016
More here from the Guardian
Could Pfizer's record fine for unfair prices change the industry's practices? https://t.co/EuULJzzLFj
— Guardian Business (@BusinessDesk) December 9, 2016
You might also like
What is Market Concentration?
Study Notes
Profit Concepts Defined
Study Notes
Topical Examples of Price Discrimination
Study Notes
Price Discrimination and Economic Welfare
Topic Videos
Advantages and Disadvantages of Price Discrimination
Topic Videos
Price Discrimination and Consumer Welfare - A-Level Economics Essay Walkthrough
Practice Exam Questions
3.4.5 Monopoly Entry Barriers (Edexcel A-Level Economics Teaching PowerPoint)
Teaching PowerPoints

Un-bottling the Baby Formula Market: Why Competition Matters for Families
12th November 2024